NCT02357992View on ClinicalTrials.gov

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

April 5, 2010

Primary Completion Date

September 17, 2021

Study Completion Date

September 17, 2021

Conditions
Lung Cancer
Interventions
RADIATION

Stereotactic Body Radiotherapy (SABR)

SABR once a day for 3-4 days in a row, 50Gy in 4 fractions for central tumor, or 54Gy in 3 fractions for peripheral tumor.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Varian Medical Systems
All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT02357992 - Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy | Biotech Hunter | Biotech Hunter